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Abstract
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality. Pulmonary
rehabilitation (PR) is offered to patients with functional breathlessness. However, access to PR is limited.
The objective of this study was to evaluate whether a 4-week education and exercise programme offered to
COPD patients with Medical Research Council (MRC) dyspnoea 1–2 improves disease self-management.
Patients were recruited by their GP to attend four weekly 2-h sessions provided by a multidisciplinary
team. Patients completed outcome measures before and after the program. Forty-two patients entered the
programme and 26 out of 42 (61.9%) completed all sessions. The Bristol COPD Knowledge Questionnaire and
Patient Activation Measure improved (both p  0.001). Disease burden was not reduced according to the
COPD assessment test. All patients accepted a referral for ongoing exercise. Fourteen current smokers
(81.3%) accepted a referral for smoking cessation, three patients with anxiety or depression (37.5%)
accepted a psychological therapies referral. The programme improved COPD disease knowledge, patient
activation and stimulated referrals to further services supporting disease management. Randomised
controlled trials are warranted for similar interventions for COPD patients with early stage disease.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a
major global cause of morbidity and mortality.1 The
gold standard evidence-based intervention for people
with COPD who are functionally limited by breath-
lessness (Medical Research Council Dyspnoea Score
of 3 or more) is pulmonary rehabilitation (PR). PR
improves COPD patients’ quality of life, exercise
capacity, muscle strength and dyspnoea. However,
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access to PR and adherence to programmes remain
suboptimal.2–4 Current referral criteria to enter PR are
based on the MRC dyspnoea scale with some PR
programmes funded to also include individuals who
have had a recent exacerbation requiring hospitalisa-
tion. The majority of these individuals will have sta-
ble MRC breathlessness levels of three or more.
Individuals with an MRC score of 2 should be referred
to PR, as it is a British Thoracic Society Quality Stan-
dard. However, fewer programmes accept referrals
for MRC 2 patients compared to MRC 3–5.5 Further-
more, according to current UK referral criteria, it is
not recommended that patients are referred primarily
on the basis of anxiety or depression, which are com-
mon in COPD6,7 and may also be improved with PR.8
For individuals with MRC 1–2 breathlessness who
are not referred to PR, current recommendations for
levels of exercise/physical activity remain the same as
for the general population in regard to performing 150
min of moderate intensity endurance activity and
strength training at least twice a week. These recom-
mendations may not be appropriate, as COPD patients
have greater energy expenditure for activities of daily
living compared to healthy controls.9 The primary
healthcare contacts for these patients will be in Pri-
mary Care. However, general practitioners’ (GPs)
knowledge of physical activity guidance is poor.10
In addition to exercise, other recommendations for
people with COPD who are either early in their dis-
ease process or have less severe dyspnoea include
smoking cessation, inhaled therapy with bronchodila-
tors and receiving vaccinations for flu and pneumo-
nia. In many other chronic conditions, individuals
receive self-management advice close to diagnosis
such as in diabetes and chronic heart failure.11,12 This
is not always the case for people with COPD. The
evidence for self-management intervention benefit for
people with COPD is from those who have more
severe disease and symptom burden.13,14 Therefore,
there is currently a gap in self-management evidence
and service provision for individuals with COPD with
low levels of reported breathlessness and has been
identified a priority area of research need recom-
mended by the Chartered Society of Physiotherapy
2017 research priorities. This research aimed to eval-
uate whether the programme was successful in help-
ing patients to self-manage their condition; as
measured by whether their disease knowledge
improved and symptoms and disease burden reduced
as a result of attending the programme.
Methods
The British Lung Foundation, Whittington Health
NHS Trust and University College London Hospitals
(UCLH) were commissioned by Islington Clinical
Commissioning Group (CCG) to deliver a programme
for patients in Islington with COPD with a dyspnoea
score of less than 3 on the MRC scale and not experi-
encing frequent exacerbations. Patients who were
experiencing severe exacerbations were eligible for
a standard PR programme.
Public and patient involvement
Islington is an urban London Borough with higher
levels of deprivation and smoking prevalence com-
pared to the UK national average.15 Four multidisci-
plinary COPD workshops were held at the start of
2012 as Islington was starting to develop its integrated
care strategy. The workshops welcomed input from
patients, commissioners, local public health teams,
GPs, practice nurses, consultants and voluntary orga-
nisations and sought to review the current pathway
and services and understand whether any gaps
existed. One key point, brought up by COPD patients
during discussions about self-management, was that
while there was a well-established PR programme for
those patients with MRC of 3 or more in Islington,
there was no equivalent programme for patients who
are newly diagnosed or who had less severe COPD.
Patients felt that a support programme available early
on in the course of their disease would have helped
them to better understand their condition and possibly
prevent or slow their condition from worsening.
Study design and participants
In this 8-month pilot study, 67 participants with
COPD and MRC dyspnoea score of 1–2 were
recruited. Potential participants were identified by
GPs from their registers. GPs contacted patients iden-
tified from this register and asked them if they want to
take part. Only if individuals agreed were their details
then passed on to the research team. Potential patients
were also identified when they attended their GP sur-
gery for other reasons or for a COPD annual review.
Inclusion criteria
Any patient registered with an Islington GP with a
spirometry and clinician confirmed the diagnosis of
COPD and an MRC dyspnoea score of 1 or 2.
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Exclusion criteria
People who had significant unstable cardiac or other
disease that would make exercise unsafe or prevent
programme participation were excluded. People who
were unable to walk or whose ability to walk safely
and independently was significantly impaired due to
non-respiratory-related conditions were also
excluded. People unable to participate in a group
environment or for whom group sessions were not
suitable were excluded, for example, extreme frailty,
sight or balance impairment, or for whom mental
health, cognitive, personality or other communication
barriers that make group work inappropriate. Referral
back to the GP occurred if the referral was inappropri-
ate for any of the above reasons.
Outcomes
Individuals who consented to participate were clini-
cally assessed by a senior physiotherapist for entry
onto the programme. Participants were asked to
complete baseline patient reported outcome mea-
sures and repeat these at the end of the programme.
At 3 and 6 months post programme, the COPD
Assessment Test (CAT) and Patient Activation Mea-
sure (PAM) were completed again with a member of
staff at the British lung foundation (BLF) over the
telephone. Loss of data at follow-up was recorded
by the BLF. Patient reported outcome measures
included The Bristol COPD Knowledge Question-
naire (BCKQ)16 to assess patient disease knowledge.
The BCKQ is self-administered and comprises of 13
domains. Each domain consists of five statements
regarding COPD each answered with a ‘true’, ‘false’
or ‘don’t know’. The CAT was chosen17 to assess
disease burden. This questionnaire comprises of
eight questions scored from 0 to 5 on extent to
which their disease limits them regarding symptoms
and activities of daily living. A score of 40 indicates
the greatest disease burden and a score of 5 is the
upper limit of normal for ‘healthy’ smokers. A pre-
viously established minimal clinical important dif-
ference for PR is between 2 and 3.18,19 The Hospital
Anxiety and Depression scale (HADS)20 was used
to assess anxiety and depression. On the HADS,
scores of 8 or more suggest possible anxiety or
depression, and scores of 11 or more indicate prob-
able clinically significant disease. A change in score
of 1.5 is the minimal clinically important difference
(MCID) for the HAD.21 The PAM22 was used to
assess how engaged and knowledgeable individuals
were with their healthcare and self-management. It
consists of 13 items with overall scoring from 0 to
100. The higher the score, the greater the disease
knowledge and confidence to manage a health con-
dition. Feasibility outcomes included patient atten-
dance and satisfaction with the programme and the
extent to which the programme stimulated ongoing
referrals to other community services. The primary
outcome measure piloted was the PAM. Participants
were asked to answer a patient satisfaction question-
naire at the end of the programme (Appendix 1).
Ethics
This study was approved by London – Harrow
research ethics committee (REC no: 14/LO/1355)
The programme
Participants attended four weekly programme ses-
sions in the evening lasting 2 h. These sessions
were supervised by a senior physiotherapist and
rehabilitation assistant. Other Allied Health
Professional, nursing and medical colleagues
contributed to the education component of the
programme. Each session consisted of a brief
introduction, education component, at least 45 min
of exercise intervention and a closing debrief and
planning period. Full details of the programme can
be found in Figure 1:
All clinicians running the programme completed
The Advanced Development Programme (ADP). The
ADP trains healthcare professionals in strategies and
skills to support people with long-term conditions to
optimally self-manage using the principles of colla-
borative agenda setting, goal setting and action plan-
ning and goal follow-up. These principles are based
on the Chronic Care Model theory.23
During aerobic exercise, patients were asked to try
to become moderately or somewhat severely breath-
less using the Modified Borg Dyspnoea scale. During
resistance exercises, patients were encouraged to gra-
dually progress the weight or the number of sets per-
formed according to being able to achieve the correct
technique without reaching repetition failure for a
consecutive week. The aim of the exercise pro-
gramme was not to alter the physiology of the patient
over four sessions. It was to increase the patient’s
knowledge regarding the importance of exercise to
reduce progression of their condition and to increase
their confidence exercising.
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Statistical analysis
Statistical analysis was performed using STATA
15. Change following participation in the pro-
gramme was evaluated for categorical/ordinal
grouped data and non-normally distributed data
using the Wilcoxon rank test. Continuous nor-
mally distributed paired data were analysed using
a two-tailed paired t test. The level of significance
was set at p < 0.05. Data were analysed by
research team members with no involvement in
research participant clinical care to reduce bias.
Missing data at follow-up are acknowledged in the









Intro to principles and instrucon on 
exercises and equipment
Close:
Goals, Acon plans, Exercise Booklet 
Week 2:
Introducon:
Managing COPD, Recap on Week 1, 
review acon plans
Educaon:
Treatments for COPD including 
smoking cessaon, inhalers 
Exercise:
45 mins of group warm up, strength 
and endurance exercise and cool 
down.
Close:
Goals tailored around learning this 
far, inhaler use and physical acvity
Week 4:
Introducon:
Recap from previous week, Living 
with COPD, review acon plans.
Educaon:
Holidays, work and finance. 
Signposng other services (healthy 
eang, smoking cessaon, breathe 
easy)
Exercise:
45 mins of group warm up, strength 
and endurance exercise and cool 
down.
Close:




Recap from previous week, review 
acon plans.
Educaon:
Exacerbaons recognion and 
management
Exercise:
45 mins of group warm up, strength 
and endurance exercise and cool 
down.
Close:
Review goals and new goals set for 
next week.
Figure 1. Weekly session content.
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Results
Baseline demographics
Eighty referrals were received by the BLF from GP’s.
Thirty participants were not booked into a programme.
Participant reported reasons for not being booked to
start a programme include being too busy,1 did not
receive information,1 language difficulties,1 no answer
on the phone,3 new carer responsibilities,1 class can-
celled due to low numbers,15 no diagnosis of COPD,1
no reason stated,3 work commitments3 and timing
inappropriate.1 Eight were booked to start but did not
participate further without further information avail-
able on reasons why. Therefore, 42 participants entered
the programme (Figure 2). Recruitment was targeted
from practices with high numbers of COPD patients
with MRC 1–2. However, it is not known how many
eligible patients were approached by GPs, and how
many individuals declined a referral to the programme.
Participants had a mean age of 62 at recruitment. Par-
ticipants had moderate COPD and the majority
(57.1%) was ex-smokers. Patient activation levels were
low, and they had poor knowledge about their condi-
tion. Baseline demographics are presented in Table 1.
Parcipants booked into the 
programme
N = 50
Parcipants not booked into 
programme prior to January 2016:
N = 30
Parcipants booked but did not 
start a programme
N = 8
Parcipants who did not complete 
the programme:
N = 7
Parcipants who started a 
programme
N = 42
Parcipants who completed a 
programme (At least 3 of four 
sessions):
N = 35
Parcipants who completed 
outcome measures on compleon 
of programme:
N= 29
Parcipants who did not complete 
outcome measures on compleon:
N= 6
Number of parcipants who 
completed quesonnaires at 3-6 
months:  
N = 27
Parcipants referred to Brish Lung 
Foundaon:
N = 80
Figure 2. Patient flow diagram.
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Changes in outcomes following the COPE
programme
Thirty-five (83.3%) of the 42 participants who entered
the programme attended three of four sessions and
were classified as ‘completers’. The reasons for seven
participants not being able to attend the last session
included work commitments,2 family reasons2 and
having another appointment at the same time1 or no
reason given.2 No participants changed smoking status
as a result of completing the programme. However, 14
(81.3%) current smokers agreed to be referred to a
smoking cessation service. Baseline HADS scores
were clinically significant in eight participants, three
(37.5%) of whom accepted a referral to a local Increas-
ing Access to Psychological Therapies (IAPT) service.
Twenty-six (100%) accepted a referral to an ongoing
exercise programme. Reasons for non-completion or
attendance were varied. Timing of the classes, work
commitments, carer responsibilities, problems with
parking and inability to attend during school holidays
were reasons given. No adverse events were reported
by participants. Twenty-one participants (77.8%) were
followed up at 3 months. Six participants (22.2%)
could not be contacted at 3 months post completion
but were contacted at 6 months post completion. Out-
come changes from before and after the programme are
presented in Table 2.
When participants were telephoned by someone
from the BLF at 3 months post programme com-
pletion, one participant had quit smoking and seven
participants had started or completed an exercise
on referral scheme. At 6 months, a further three
participants had quit smoking and a further two
participants had started or completed exercise on
prescription.
Patient satisfaction questionnaire data
Twenty-five individuals completed and returned the
patient satisfaction questionnaire at the end of the
programme. Regarding ratings about the venue, 82
out of 119 (68.9%) returned answers rating the venue
as excellent with only one answering ‘poor’ (0.8%).
Table 3 illustrates other service ratings.
Participants reported that the programme acted as a
stimulus to stop smoking and maintain exercise:
This service let me understand better my condi-
tion . . . made me realise how important it is for me to
stop smoking. (P16)
I have become an expert about COPD, found it very
interesting. Since been to Whittington to stop smok-
ing. (P6)
I also found the gym very useful as it has taught us
exercise doesn’t need to end. (P4)
The knowledge gained about COPD seemed to be
most useful for participants, especially when living
with early stage COPD:
Helpful to have a mix of information, questions
answered, practical advice and experience of the gym.
Particularly helpful to have this at an early stage of
COPD. Also the links to local activities and exercise
by referral. (P3)
I didn’t know much about COPD. Useful to know I can
exercise and not worry about breathlessness. So that
helps me be more determined to stop smoking. (P16)
Clear information, clear question and answers, Exercise
information. Clear information on local groups and cen-
tres for exercise. (P21)
Individuals had negative comments about the pro-
gramme. The component that was perceived as least
useful was the smoking cessation advice for some
Table 1. Baseline demographics of participants in the
programme.a
Baseline characteristic Mean (SD/%)
Age (n ¼ 67) 62 (11.4)
Sex (F) (n ¼ 78) 46 (59%)
Time since diagnosis (years) (n¼35) 2.4 (2.7)
FEV1%Pred (n ¼ 28) 59.8 (23.9)
BMI (n ¼ 40) 24.6 (4.8)
Smoking status (n ¼ 63)
Never smoker 1 (1.6)
Ex-smoker 36 (57.1)
Current smoker 26 (41.3)
BCKQ (n ¼ 52) 29.9 (8.4)
CAT (n ¼ 50) 18.3 (7.9)
PAM (n ¼ 50) 38.1 (4.4)
HADS-A (n ¼ 50) 7.5 (4.9)
HADS-D (n ¼ 50) 6.3 (4.3)
BCKQ: Bristol COPD knowledge questionnaire; CAT: Chronic
Obstructive Pulmonary Disease Assessment Test; PAM: Patient
Activation Measure; HADS-A: Hospital Anxiety and Depression
Scale Anxiety subdomain; HADS-D: Hospital Anxiety and
Depression Scale Depression subdomain; FEV1%Pred: Forced
Expiratory volume in 1 second percent predicted; BMI: Body Mass
Index.
an represents the total number of participants who provided this
data at baseline from referral or questionnaire completion.
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who had already stopped but helpful suggestions
were made:
Smoking session: I have not smoked for at least
25 years. If you have a larger group you might consider
an alternative activity for the non-smokers. (P3)
Individuals gave support for the service and valued
the ‘expert patient’ interaction:
It should be compulsory for all COPD sufferers to come
to these classes to learn to understand what this disease
is and what you can do to help yourself. (P1)
Please keep this ongoing. Don’t cut this service. (P6)
(name) came to talk us about his health problems, was a
delight to listen to. He was very reassuring about taking
my medications. (P7)
I do hope this programme continues. It showed that
people need to talk about their diagnosis. It was
extremely helpful and I learnt a lot. Although I gave
up smoking years ago, I think longer or more sessions
on that would be useful as everyone seemed to want to
talk about that. (P15)
Discussion
Summary of main findings
The programme is a structured 4-week programme of
education and exercise for people with COPD and
MRC dyspnoea 1–2. The programme enabled partici-
pants to improve their knowledge and activation lev-
els regarding their health condition. The programme
acted as a stimulus for behaviour change with parti-
cipants accepting referrals to smoking cessation, psy-
chological therapies and ongoing exercise schemes.
All patients accepted a referral to ongoing exercise
schemes. This may be a result of the type of individual
attracted to the research study. Nevertheless, all par-
ticipants were eligible for referral to such schemes
already through their GP but were not participating
in such a scheme. Therefore, the programme may
improve access to an underutilised Primary Care
resources. Individuals with less breathlessness







Smoking status (n%) (n%) (n%)
Never smoker N (paired) ¼ 1 1 (2.7) 1 (2.7) 0 (0%) p ¼ 1.0
Ex-smoker N (paired) ¼ 20 20 (54.0) 20 (54.0) 0 (0%)
Current smoker N (paired) ¼ 16 16 (43.2) 16 (43.2) 0 (0%)
Mean (SD) Mean (SD) Mean change (95% CI)
BCKQ N (paired) ¼ 38 29.5 (8.3) 43.4 (7.8) 13.9 (11.2–16.6) p < 0.001
CAT N (paired) ¼ 38 18.7 (8.2) 18.3 (8.7) 0.4 (2.5–1.7) p ¼ 0.7
PAM N (paired) ¼ 30 38.0 (4.2) 42.1 (5.6) 4.1 (1.7–6.4) p ¼ 0.001
HADS-A N ¼ 50
HADS-D N ¼ 50
BCKQ: Bristol COPD Knowledge Questionnaire; CAT: Chronic Obstructive Pulmonary Disease Assessment Test; PAM: Patient
Activation Measure; HADS-A: Hospital Anxiety and Depression Scale Anxiety subdomain; HADS-D: Hospital Anxiety and Depression
Scale Depression subdomain.
aPost PAM is at 3 months.
Table 3. Patient satisfaction questionnaire scores.a
Very somewhat Not
How satisfied have you been with
this service?
24 1 0
Do you feel attending this exercise
class has improved your
knowledge of COPD?
24 1 0
Do you feel more confident
managing your COPD?
24 1 0
Do you feel you have an increased
knowledge about the importance
of exercise?
25 0 0
Do you feel you have gained
increased knowledge in how to
maintain an active lifestyle?
24 1 0
aIndividuals gave general comments on their satisfaction with the
programme: what was most useful, least useful and suggestions for
the future.
Lewis et al. 7
compared to those referred to standard PR pro-
grammes may have greater self-efficacy towards
exercise. Should exercise and physical activity be
maintained early in COPD, this may impact on dis-
ease progression and mortality. For example, quadri-
ceps strength predicts mortality in COPD.24
The majority (81.3%) of current smokers accepted
a referral to smoking cessation programmes. The con-
tent of the education provided, combined with the
findings of the patient satisfaction questionnaire, indi-
cate that smoking cessation advice was a core element
of the programme and acknowledgement was made of
the need to stop smoking because of increased disease
knowledge as described by participants in their qua-
litative feedback.
The mean time since participant diagnosis of
COPD in this study was 2.4 years. Therefore, indi-
viduals may be classified as newly diagnosed.
Fischer et al.25 report those COPD patients who had
been diagnosed for 5 years or more had a greater
belief that their symptoms were due to COPD, per-
ceived greater consequences, perceived that their
COPD would disable them for longer and were less
optimistic about disease controllability. Further-
more, Lewis et al.26 state that living with uncertainty
about COPD was disabling for patients who had not
yet received PR, making some feel like they were
deteriorating living with the condition, experiencing
fear, panic and an awareness of being close to death.
Interventions such as the programme offered close to
diagnosis may enable disease perceptions and result-
ing behaviour change to occur more successfully
than waiting till patients are eligible for PR, some-
times years after diagnosis.
The BCKQ significantly improved as a result of the
programme. This reflects the patient satisfaction find-
ings. There is a paucity of data on the responsiveness
to change in the BCKQ from self-management or PR
interventions. White et al.16 reported that participants
attending an 8-week bi-weekly PR programme
increased their BCKQ score by 18.3% compared to
the 20.7% in this study. These figures are similar
which validates the structure and delivery of the pro-
gramme education, supports the didactic approach
chosen and may be replicated in further studies and
clinical practice. Furthermore, this is encouraging
considering participants received a third of education
sessions compared to traditional PR programmes.
The PAM score improved after the programme,
suggesting that the programme provides an
environment where individuals can modify their
health-seeking behaviour, although the average post
programme figure of 41.8 indicates that this sample
remained in the lowest level of activation towards
their health. This level of activation means that parti-
cipants were disengaged and overwhelmed by their
respiratory disease. For comparison, the mean PAM
score of 4339 patients with COPD from an interna-
tional survey including UK patients was 66.75, and
the majority of participants had the highest level of
activation, meaning they had confidence and knowl-
edge to manage their condition, whereas only 15%
had the lowest level of activation.27 Of note, partici-
pants in the programme had low activation even
though all accepted a referral for ongoing exercise
and the majority for smoking cessation. The improve-
ment in PAM score with the programme was less than
that seen from PR, where a UK study found an
improvement of 7.52, from 54.91 points at baseline.28
There were no significant improvements in respira-
tory related health quality of life following the pro-
gramme. The MCID in CAT score is established for
PR and estimated between 2 and 3.19,29 PR is nor-
mally delivered at least twice weekly and run for at
least 6 weeks.30 There may be a lacking dose response
in the programme to illicit significant reduction in
disease burden.
How and why it agrees or disagrees with
the existing literature
Other self-management strategies have been trialled
in the United Kingdom incorporating education and
exercise for individuals with COPD and MRC dys-
pnoea 2.31,32 However, neither the ‘SPACE for
COPD’ trial or ‘my-PR’ trial included MRC dyspnoea
score 1 patients. Nevertheless, the education and exer-
cise recommendations provided across trials, within
the same healthcare climate, allow for comparisons to
be drawn. The ‘my-PR’ online programme of PR sup-
port achieved a mean difference reduction of 2.9
points in the CAT score and the ‘SPACE for COPD’
achieved significant improvements in CRQ-SR
domains of dyspnoea, fatigue and emotion, but not
mastery. Overall CRQ-SR scores were not presented.
Both trials also lasted for longer periods of between 6
and 7 weeks compared to the programme, and our
study may not have been achieved a significant
dose-response. The SPACE for COPD programme
also administered the BCKQ before and after their
6-week intervention. There was a mean improvement
of 2.79 points compared with 13.9 points in our study.
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This may highlight the benefits of face-to-face edu-
cation and the ability to ask questions. It may also
suggest that COPD patients may be more amenable
to behaviour change at a point closer to diagnosis with
milder disease burden, because they are less likely to
consider their condition a chronic illness.25 The
‘SPACE for COPD’ also had favourable rates of par-
ticipant smoking cessation at 6-month follow up com-
pared to usual care. Our findings also indicate that
holistic self-management interventions in individuals
with MRC of less than 3 stimulate behaviour change
and therefore may alter disease progression in the
long term.
Strengths and the limitations of this study
There was no control group included in this study.
Our results indicate that further randomised con-
trolled trials are indicated for self-management sup-
port with individuals with COPD and MRC
breathlessness scores of 1–2.
There were no functional/exercise capacity mea-
sures, and limited spirometric measurements avail-
able from referral to the programme. These data
relied on the quality of GP administration of the
referral. This limits interpretation of the results in
comparison with other studies. Such endpoints are
recommended for future trials.
There are missing data at follow-up. This is com-
mon in PR when participant drop out indicates that
they do not return for a final assessment and partici-
pants had the right to withdraw from this study with-
out giving reason and so this is hard to control for.
Future studies using these outcomes should distribute
all patient reported outcome measures at baseline,
4 weeks, 3 and 6 months.
Implications for future research or clinical
practice
To the authors’ knowledge, the programme is the first
of its kind to be researched in the United Kingdom
and needed a benchmark from which to do further
research. Randomised controlled trials of similar
self-management interventions are warranted prior
to such programmes being included in practice-
based guidelines. This pilot study suggests that using
the BCKQ and PAM are useful outcome measures to
detect change in disease knowledge and patient acti-
vation. Furthermore, it is recommended that future
trials should record participant uptake of other
services such as exercise referral schemes as a mea-
sure of successful long-term activation and engage-
ment in healthcare that could potentially modify the
course of disease progression.
Conclusion
The programme of education and exercise is an effec-
tive approach to improve disease knowledge and acti-
vation of individuals with COPD and MRC dyspnoea
scores of 1–2. The programme also may promote
behavioural change by stimulating referrals to smok-
ing cessation services, psychological therapies and
exercise schemes. These activities may prevent dis-
ease progression and be particularly effective if
provided close to diagnosis. Further randomised con-
trolled trials of self-management interventions for
COPD patients not eligible for PR are warranted.
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Appendix 1
The COPE programme satisfaction questionnaire
Date________________
Q1: Where are you attending the COPE programme?:
Q2: Venue rating
Q3: How satisfied have you been with this service?
a) Very satisfied c b) Satisfied c c) Not satisfied c











Q4: Do you feel attending this exercise class has improved your knowledge of COPD?
a) Very much c b) Somewhat c c) Not at all c
Q5: Do you feel more confident managing your COPD?
a) Very much c b) Somewhat c c) Not at all c
Q6: Do you feel you have an increased knowledge about the importance of exercise?
a) Very much c b) Somewhat c c) Not at all c
Q7: Do you feel you have gained increased knowledge in how to maintain an active lifestyle?
a) Very much c b)Somewhat c c) Not at all c




















Thank you for taking the time to complete this survey.
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